Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 1/16/2023
New study finds fluvoxamine ineffective for mild to moderate COVID-19 in outpatients
Although study results have been conflicting, overall evidence does not support use of fluvoxamine for current treatment of mild to moderate COVID-19. - 1/12/2023
Be aware of possible need for pain control during IUD placement
Healthcare providers should counsel patients about what to expect during intrauterine device placement, including pain control options. - 1/10/2023
How should acute COVID-19 be managed in children?
Pediatric COVID-19 working group of AMMI Canada issues practice point on the treatment of acute COVID-19 in children. - 1/3/2023
Omicron subvariant XBB.1.5 jumps from 9.9% to 40.5% of U.S. COVID cases in two weeks
Concerns raised about another potential wave of COVID-19 cases following the busy holiday travel season. - 12/21/2022
The symptoms that stick around: Quebec researchers examine persistent symptoms following Omicron infection
Study identifies risk factors and prevalence of ongoing symptoms after SARS-CoV-2 Omicron infection in adults. - 12/20/2022
POP QUIZ: Holiday season scramble!
Happy Holidays! As you scramble to get ready for the holidays, take an “unscramble” break and try this quiz. - 12/19/2022
Updated recommendation on giving COVID-19 vaccines with other vaccines
The NACI has announced that COVID-19 vaccines may be administered concurrently with other vaccines in all authorized age groups. - 12/15/2022
Study shows importance of COVID-19 vaccine booster dose in children 5 to 11 years
A booster dose of Pfizer vaccine restored protection against Omicron, with efficacy maintained for at least three months. - 12/14/2022
POP QUIZ: Antidepressant selection
Canadian researchers recently developed the Antidepressant Decision Support Tool to assist primary care practitioners in individualizing first-line pharmacotherapy for major depressive disorder. - 12/13/2022
Nuvaxovid COVID-19 vaccine approved for adolescents and for first booster dose in adults
Protein subunit COVID-19 vaccine may be an option for individuals who are unable or not willing to receive an mRNA COVID-19 vaccine.
